Long-term in vivo survival of receptor-modified syngeneic T cells in patients with human immunodeficiency virus infection.
Walker RE, Bechtel CM, Natarajan V, Baseler M, Hege KM, Metcalf JA, Stevens R, Hazen A, Blaese RM, Chen CC, Leitman SF, Palensky J, Wittes J, Davey RT Jr, Falloon J, Polis MA, Kovacs JA, Broad DF, Levine BL, Roberts MR, Masur H, Lane HC.
Walker RE, et al. Among authors: stevens r.
Blood. 2000 Jul 15;96(2):467-74.
Blood. 2000.
PMID: 10887107
Free article.
Clinical Trial.